BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26664743)

  • 1. Prevalence and Risk Factors for Complications in Patients with Nontransfusion Dependent Alpha- and Beta-Thalassemia.
    Winichakoon P; Tantiworawit A; Rattanathammethee T; Hantrakool S; Chai-Adisaksopha C; Rattarittamrong E; Norasetthada L; Charoenkwan P
    Anemia; 2015; 2015():793025. PubMed ID: 26664743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective analysis for prevalence of complications in Thai nontransfusion-dependent Hb E/β-thalassemia and α-thalassemia (Hb H disease).
    Ekwattanakit S; Siritanaratkul N; Viprakasit V
    Am J Hematol; 2018 May; 93(5):623-629. PubMed ID: 29359464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PREVALENCE AND RISK FACTORS FOR CARDIAC IRON OVERLOAD AND CARDIOVASCULAR COMPLICATIONS AMONG PATIENTS WITH THALASSEMIA IN NORTHERN THAILAND.
    Tantiworawit A; Tapanya S; Phrommintikul A; Saekho S; Rattarittamrong E; Norasetthada L; Chai-Adisaksopha C; Hantrakool S; Charoenkwan P; Chattipakorn N
    Southeast Asian J Trop Med Public Health; 2016 Nov; 47(6):1335-42. PubMed ID: 29634199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Risk Factors for Cardiac and Liver Iron Overload in Adults with Thalassemia in Malaysia.
    Ngim CF; Lee MY; Othman N; Lim SM; Ng CS; Ramadas A
    Hemoglobin; 2019 Mar; 43(2):95-100. PubMed ID: 31179787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoiesis and Iron Homeostasis in Non-Transfusion-Dependent Thalassemia Patients with Extramedullary Hematopoiesis.
    Huang Y; Liu R; Wei X; Liu J; Pan L; Yang G; Lai Y
    Biomed Res Int; 2019; 2019():4504302. PubMed ID: 30834265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luspatercept's use in a patient with transfusion-dependent beta-thalassemia and intrathoracic extramedullary hematopoiesis (EMH).
    Seijari MN; Alshurafa A; Yassin MA
    Clin Case Rep; 2024 May; 12(5):e8795. PubMed ID: 38736568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiologic and clinical characteristics of nontransfusion-dependent thalassemia in the United States.
    Vichinsky E; Cohen A; Thompson AA; Giardina PJ; Lal A; Paley C; Cheng WY; McCormick N; Sasane M; Qiu Y; Kwiatkowski JL
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27067. PubMed ID: 29637688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of disease-related complications and management in adult patients with thalassemia: A multi-center study in Thailand.
    Chuncharunee S; Teawtrakul N; Siritanaratkul N; Chueamuangphan N
    PLoS One; 2019; 14(3):e0214148. PubMed ID: 30893381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spanish registry of hemoglobinopathies and rare anemias (REHem-AR): demographics, complications, and management of patients with β-thalassemia.
    Bardón-Cancho EJ; Marco-Sánchez JM; Benéitez-Pastor D; Payán-Pernía S; Llobet AR; Berrueco R; García-Morin M; Beléndez C; Senent L; Acosta MJO; Pleguezuelos IP; Velasco P; Collado A; Moreno-Carbonell M; Argilés B; de Soto IP; Del Mar Bermúdez M; Salido Fiérrez EJ; Blanco-Álvarez A; Navarro PG; Cela E
    Ann Hematol; 2024 May; 103(5):1525-1539. PubMed ID: 38519604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marital status and paternity in patients with Transfusion- Dependent Thalassemia (TDT) and Non Transfusion-Dependent Thalassemia (NTDT): an ICET - A survey in different countries.
    De Sanctis V; Soliman AT; El-Hakim I; Christou S; Mariannis D; Karimi M; Ladis V; Kattamis A; Daar S; Yassin M; Canatan D; Galati MC; Raiola G; Campisi S; Kakkar S; Kaleva V; Saki F; Ellinides A; Pikis G; Christodoulides C; Abdulla M; Di Maio S; Theodoridis C; Elsedfy H; Kattamis C
    Acta Biomed; 2019 Sep; 90(3):225-237. PubMed ID: 31580308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO
    Taher A; Viprakasit V; Cappellini MD; Sutcharitchan P; Ward R; Mahmoud D; Laadem A; Khan A; Gwaltney C; Harding G; Attie K; Zhang X; Zou J; Pariseau J; Hu XH; Kattamis A
    Am J Hematol; 2019 Feb; 94(2):171-176. PubMed ID: 30394579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Molecular Characteristics of Non-Transfusion-Dependent Thalassemia in Kuwait.
    Adekile AD; Azab AF; Al-Sharida SI; Al-Nafisi BA; Akbulut N; Marouf RA; Mustafa NY
    Hemoglobin; 2015; 39(5):320-6. PubMed ID: 26076396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension in non-transfusion-dependent thalassemia: Correlation with clinical parameters, liver iron concentration, and non-transferrin-bound iron.
    Inthawong K; Charoenkwan P; Silvilairat S; Tantiworawit A; Phrommintikul A; Choeyprasert W; Natesirinilkul R; Siwasomboon C; Visrutaratna P; Srichairatanakool S; Chattipakorn N; Sanguansermsri T
    Hematology; 2015 Dec; 20(10):610-7. PubMed ID: 25964094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morbidities in non-transfusion-dependent thalassemia.
    Saliba AN; Taher AT
    Ann N Y Acad Sci; 2016 Mar; 1368(1):82-94. PubMed ID: 27186941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between pre-transfusion hemoglobin levels and thalassemia complications.
    Wanchaitanawong W; Tantiworawit A; Piriyakhuntorn P; Rattanathammethee T; Hantrakool S; Chai-Adisaksopha C; Rattarittamrong E; Norasetthada L; Niprapan P; Fanhchaksai K; Charoenkwan P
    Hematology; 2021 Dec; 26(1):1-8. PubMed ID: 33357151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of low bone mass among adolescents with nontransfusion-dependent hemoglobin E/β-thalassemia and its relationship with anemia severity.
    Nakavachara P; Petchkul J; Jeerawongpanich K; Kiattisakthavee P; Manpayak T; Netsakulnee P; Chaichanwattanakul K; Pooliam J; Srichairatanakool S; Viprakasit V
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28801997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnitude of Bone Disease in Transfusion-Dependent and Non-Transfusion-Dependent β-Thalassemia Patients.
    Shamoon RP; Yassin AK; Omar N; Saeed MD; Akram R; Othman NN
    Cureus; 2024 Mar; 16(3):e56012. PubMed ID: 38606231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extramedullary hematopoiesis is associated with lower cardiac iron loading in chronically transfused thalassemia patients.
    Ricchi P; Meloni A; Spasiano A; Neri MG; Gamberini MR; Cuccia L; Caruso V; Gerardi C; D'Ascola DG; Rosso R; Campisi S; Rizzo M; Terrazzino F; Vangosa AB; Chiodi E; Missere M; Mangione M; Positano V; Pepe A
    Am J Hematol; 2015 Nov; 90(11):1008-12. PubMed ID: 26228763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deferasirox for the treatment of iron overload in non-transfusion-dependent thalassemia.
    Taher AT; Temraz S; Cappellini MD
    Expert Rev Hematol; 2013 Oct; 6(5):495-509. PubMed ID: 24083402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for extramedullary hematopoiesis in patients with transfusion-dependent β-thalassemia (TDT): A systematic review.
    Ata F; Subahi EA; Choudry H; Yassin MA
    Health Sci Rep; 2021 Dec; 4(4):e429. PubMed ID: 34761125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.